Published in Blood Weekly, March 24th, 2011
"We observed a distinct response pattern for most cases with a 17p deletion (n=16) or a sole TP53 mutation (n=8), but not all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.